Core Life Analytics
Cloud data analytics services for life sciences. We help biologists to find new cures.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | €0.0 | round |
* | €1.0m | Series A | |
| Total Funding | 000k | ||
| USD | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| % growth | - | 200 % | 83 % | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Core Life Analytics operates in the life sciences sector, providing a cloud-based data analytics platform known as HC StratoMineR. This platform is designed to facilitate the analysis of phenotypic features of stem cells across multiple experiments. The primary users of HC StratoMineR are researchers and facilities involved in high content screening and stem cell research. The platform eliminates the need for complex local IT infrastructure and command line programming, making it accessible to a broader range of users. Core Life Analytics generates revenue through subscription-based models, offering free trials to attract new users and converting them into paying customers. The company operates in the global life sciences market, targeting academic institutions, research facilities, and biotech companies. By accelerating the pace of discovery and reducing costs, Core Life Analytics provides a valuable tool for high content data analysis.
Keywords: data analytics, life sciences, stem cells, phenotypic analysis, cloud-based, high content screening, subscription model, research facilities, biotech, discovery acceleration.